Platelet Rich Plasma (PRP) Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Pure Platelet Rich Plasma, Pure Platelet Rich Fibrin, Leukocyte-Platelet Rich Fibrin, Others), By Application (General Surgery, Neurosurgery, Cardiac Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others), and Region  

The global platelet rich plasma (PRP) market size was valued at US$ 492.3 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2030. Platelet Rich Plasma (PRP) Market is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet-rich plasma (PRP) therapy is usually done by utilizing the body's natural healing process. In this therapy, a concentration of platelets is injected into the damaged tendons, joints, and ligaments to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others. The major variables that are considerably boosting the target market's growth are Some of the key determinants driving the platelet-rich plasma market globally are an increase in the number of orthopedic surgeries and sports injuries, an increase in the number of cosmetic surgeries, growing awareness about platelet rich plasma treatment in dental health, approval of new devices and the discovery of new application areas, rising geriatric population, and a surge in awareness among the global population. The significant volatility in the price of platelet-rich plasma therapy, on the other hand, as well as inadequate reimbursement policies, would stifle the platelet-rich plasma market's growth.